SCHEMBL24066906

SCHEMBL24066906

CCN(CC)C(C)NCCN

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.30
CYP2C19 P33261 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7035089 0.75
SCHEMBL3784124 0.74 ALDH1A1 (0.40) CYP2C9CYP2C19
SCHEMBL9244557 0.73 EPHX1 (0.41) CYP2C9CYP2C19
SCHEMBL28988992 0.73 EPHX1 (0.41) CYP2C9CYP2C19
SCHEMBL9407144 0.71 ALDH1A1 (0.40)
SCHEMBL6747100 0.69
SCHEMBL9407143 0.69 ALDH1A1 (0.31)
SCHEMBL506529 0.68 CA12 (0.39) CYP2C9CYP2C19
SCHEMBL6885477 0.68 FDPS (0.32)
SCHEMBL122917 0.68

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210369817-A1 CONJUGATES OF A FACTOR VIII MOIETY HAVING AN OXIME-CONTAINING LINKAGE NEKTAR THERAPEUTICS 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210369817-A1 CONJUGATES OF A FACTOR VIII MOIETY HAVING AN OXIME-CONTAINING LINKAGE F8, F13B, F13A1 CYP2C9 191/4885CYP2C19 421/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.